Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report) shot up 4.3% during trading on Monday . The stock traded as high as $16.44 and last traded at $16.17. 38,413 shares changed hands during mid-day trading, a decline of 53% from the average session volume of 82,291 shares. The stock had previously closed at $15.51.
Gyre Therapeutics Stock Up 2.8 %
The stock has a market capitalization of $1.36 billion, a PE ratio of -0.75 and a beta of 2.11. The stock has a 50-day simple moving average of $17.39.
Gyre Therapeutics Company Profile
Gyre Therapeutics, Inc, a biopharmaceutical company, primarily focuses on the development and commercialization of Hydronidone for the treatment of Metabolic Dysfunction Associated Steatohepatitis in the United States. Its Hydronidone is also being evaluated for the treatment of liver fibrosis across a spectrum of chronic liver diseases.
Featured Stories
- Five stocks we like better than Gyre Therapeutics
- How to Read Stock Charts for Beginners
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Merger or Not, Albertson’s Companies is a Good Buy
- Basic Materials Stocks Investing
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Gyre Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyre Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
